ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 203 filers reported holding ZAI LAB LTD in Q4 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,152,126 | -13.3% | 34,640 | -20.0% | 0.04% | -12.0% |
| Q4 2022 | $1,329,310 | -10.2% | 43,300 | 0.0% | 0.05% | -18.0% |
| Q3 2022 | $1,481,000 | -1.4% | 43,300 | 0.0% | 0.06% | +3.4% |
| Q2 2022 | $1,502,000 | -21.1% | 43,300 | 0.0% | 0.06% | -11.9% |
| Q1 2022 | $1,904,000 | -30.0% | 43,300 | 0.0% | 0.07% | -23.9% |
| Q4 2021 | $2,721,000 | -31.2% | 43,300 | +15.4% | 0.09% | -30.7% |
| Q3 2021 | $3,955,000 | -40.4% | 37,523 | 0.0% | 0.13% | -41.2% |
| Q2 2021 | $6,641,000 | +32.6% | 37,523 | 0.0% | 0.22% | +25.6% |
| Q1 2021 | $5,007,000 | -1.4% | 37,523 | 0.0% | 0.17% | -3.4% |
| Q4 2020 | $5,078,000 | +62.7% | 37,523 | 0.0% | 0.18% | +52.1% |
| Q3 2020 | $3,121,000 | +1.3% | 37,523 | 0.0% | 0.12% | 0.0% |
| Q2 2020 | $3,082,000 | +59.5% | 37,523 | 0.0% | 0.12% | +34.5% |
| Q1 2020 | $1,932,000 | +23.8% | 37,523 | 0.0% | 0.09% | +47.5% |
| Q4 2019 | $1,561,000 | +28.6% | 37,523 | 0.0% | 0.06% | +11.3% |
| Q3 2019 | $1,214,000 | – | 37,523 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |